nach oben

Archives of Orthopaedic and Trauma Surgery

Erschienen in:

01.04.2015 | Orthopaedic Surgery

Pathogenesis and prevention strategies of heterotopic ossification in total hip arthroplasty: a narrative literature review and results of a survey in Germany

verfasst von: S. Winkler, B. Craiovan, F. Wagner, M. Weber, J. Grifka, T. Renkawitz

Erschienen in: Archives of Orthopaedic and Trauma Surgery | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Heterotopic ossification (HO) after THA can lead to pain, impaired range of motion and possibly revision surgery. This article summarizes current literature on the pathogenesis of HO in THA and trauma. Second, it presents the results of a survey on prophylactic concepts for HO in Germany.

Materials and methods

A narrative literature review was conducted by searching three databases (Pubmed, ScienceDirect, the Cochrane library) on the aetiology of HO. Between 2013 and 2014, a questionnaire was sent to 119 orthopaedic and trauma surgery departments in Germany.

Results

The acquired form of HO seems to develop after tissue trauma, which induces a local inflammation. A change in tissue conditions, multiple signalling pathways and involvement of several different cell types seem to promote enchondral ossification and finally HO formation. The feed back rate of the survey was 67 %. Eighty-seven percent of all departments currently administer NSAIDs with a mean time span of 3 weeks after surgery for oral prophylaxis. Prophylactic perioperative irradiation is performed in 64 % of trauma/orthopaedic departments if the patient is at risk for HO with a mean dosage of 7 Gy.

Conclusions

Basic research detected new pathways and cell signalling mechanisms of HO pathogenesis, which could offer new treatment and prophylaxis options in the near future. So far, there is no uniform strategy for the clinical prophylaxis of HO in THA. Guidelines and new clinical trials need to be developed to further reduce HO rates in THA.

Adegbite NS, Xu M, Kaplan FS et al (2008) Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. Am J Med Genet A 146A:1788–1796. doi:10.1002/ajmg.a.32346 CrossRefPubMedCentralPubMed

Pignolo RJ, Shore EM, Kaplan FS (2011) Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis 6:80. doi:10.1186/1750-1172-6-80 CrossRefPubMedCentralPubMed

Macfarlane RJ, Ng BH, Gamie Z et al (2008) Pharmacological treatment of heterotopic ossification following hip and acetabular surgery. Expert Opin Pharmacother 9:767–786. doi:10.1517/14656566.9.5.767 CrossRefPubMed

Hoff P, Rakow A, Gaber T et al (2013) Preoperative irradiation for the prevention of heterotopic ossification induces local inflammation in humans. Bone 55:93–101. doi:10.1016/j.bone.2013.03.020 CrossRefPubMed

Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr (1973) Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 55:1629–1632PubMed

Board TN, Karva A, Board RE et al (2007) The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty. J Bone Joint Surg Br 89:434–440. doi:10.1302/0301-620X.89B4.18845 CrossRefPubMed

AWMF-German Study Group for the Council for International Organizations of Medical Sciences CIOMS. http://www.awmf.org/. Accessed 17 Sep 2013

Shore EM, Xu M, Feldman GJ et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38:525–527. doi:10.1038/ng1783 CrossRefPubMed

Jackson W, Aragon A, Djouad F et al (2009) Mesenchymal progenitor cells derived from traumatized human muscle. J Tissue Eng Regen Med 3:129–138. doi:10.1002/term.149 CrossRefPubMedCentralPubMed

10.

Forsberg JA, Potter BK (2010) Heterotopic ossification in wartime wounds. J Surg Orthop Adv 19:54–61PubMed

11.

Kan L, Kessler JA (2011) Animal models of typical heterotopic ossification. J Biomed Biotechnol 2011:309287. doi:10.1155/2011/309287 CrossRefPubMedCentralPubMed

12.

Jackson WM, Aragon AB, Onodera J et al (2011) Cytokine expression in muscle following traumatic injury. J Orthop Res 29:1613–1620. doi:10.1002/jor.21354 CrossRefPubMedCentralPubMed

13.

Lounev VY, Ramachandran R, Wosczyna MN et al (2009) Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 91:652–663. doi:10.2106/JBJS.H.01177 CrossRefPubMedCentralPubMed

14.

Kan L, Liu Y, McGuire TL et al (2009) Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. Stem Cells 27:150–156. doi:10.1634/stemcells.2008-0576 CrossRefPubMedCentralPubMed

15.

Shore EM, Kaplan FS (2010) Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol 6:518–527. doi:10.1038/nrrheum.2010.122 CrossRefPubMedCentralPubMed

16.

Medici D, Shore EM, Lounev VY et al (2010) Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16:1400–1406. doi:10.1038/nm.2252 CrossRefPubMedCentralPubMed

17.

Li M, Thompson DD, Paralkar VM (2007) Prostaglandin E(2) receptors in bone formation. Int Orthop 31:767–772. doi:10.1007/s00264-007-0406-x CrossRefPubMedCentralPubMed

18.

Rodenberg E, Azhdarinia A, Lazard ZW et al (2011) Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model. Tissue Eng Part A 17:2487–2496. doi:10.1089/ten.TEA.2011.0007 CrossRefPubMed

19.

Wosczyna MN, Biswas AA, Cogswell CA, Goldhamer DJ (2012) Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res 27:1004–1017. doi:10.1002/jbmr.1562 CrossRefPubMedCentralPubMed

20.

Salisbury EA, Lazard ZW, Ubogu EE et al (2012) Transient brown adipocyte-like cells derive from peripheral nerve progenitors in response to bone morphogenetic protein 2. Stem Cells Trans Med 1:874–885. doi:10.5966/sctm.2012-0090 CrossRef

21.

Shimono K, Morrison TN, Tung W et al (2010) Inhibition of ectopic bone formation by a selective retinoic acid receptor alpha-agonist: a new therapy for heterotopic ossification? J Orthop Res 28:271–277. doi:10.1002/jor.20985 PubMed

22.

Kan L, Mutso AA, McGuire TL et al (2013) Opioid signaling in mast cells regulates injury responses associated with heterotopic ossification. Inflamm Res. doi:10.1007/s00011-013-0690-4 PubMed

23.

Oishi T, Uezumi A, Kanaji A et al (2013) Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells. PLoS One 8:e56641. doi:10.1371/journal.pone.0056641 CrossRefPubMedCentralPubMed

24.

Lecourt S, Lepelletier Y, Vanneaux V et al (2012) Human muscle progenitor cells displayed immunosuppressive effect through galectin-1 and semaphorin-3A. Stem Cells Int 2012:412610. doi:10.1155/2012/412610 CrossRefPubMedCentralPubMed

25.

Nesti LJ, Jackson WM, Shanti RM et al (2008) Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am 90:2390–2398. doi:10.2106/JBJS.H.00049 CrossRefPubMedCentralPubMed

26.

Bulken-Hoover JD, Jackson WM, Ji Y et al (2012) Inducible expression of neurotrophic factors by mesenchymal progenitor cells derived from traumatically injured human muscle. Mol Biotechnol 51:128–136. doi:10.1007/s12033-011-9445-z CrossRefPubMed

27.

Jackson WM, Alexander PG, Bulken-Hoover JD et al (2013) Mesenchymal progenitor cells derived from traumatized muscle enhance neurite growth. J Tissue Eng Regen Med 7:443–451. doi:10.1002/term.539 CrossRefPubMedCentralPubMed

28.

Jackson WM, Nesti LJ, Tuan RS (2010) Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther 10:505–517. doi:10.1517/14712591003610606 CrossRefPubMedCentralPubMed

29.

Kan L, Peng C-Y, McGuire TL, Kessler JA (2013) Glast-expressing progenitor cells contribute to heterotopic ossification. Bone 53:194–203. doi:10.1016/j.bone.2012.12.008 CrossRefPubMedCentralPubMed

30.

Duran JM, Makarewich CA, Sharp TE et al (2013) Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res 113:539–552. doi:10.1161/CIRCRESAHA.113.301202 CrossRefPubMed

31.

Zhu H, Guo Z-K, Jiang X-X et al (2010) A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 5:550–560. doi:10.1038/nprot.2009.238 CrossRefPubMed

32.

Kan L, Kessler JA (2014) Evaluation of the cellular origins of heterotopic ossification. Orthopedics 37:329–340. doi:10.3928/01477447-20140430-07 CrossRefPubMed

33.

Kluk MW, Ji Y, Shin EH et al (2012) Fibroregulation of mesenchymal progenitor cells by BMP-4 after traumatic muscle injury. J Orthop Trauma 26:693–698. doi:10.1097/BOT.0b013e3182712adf CrossRefPubMed

34.

Lencel P, Delplace S, Pilet P et al (2011) Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification. Lab Invest 91:1434–1442. doi:10.1038/labinvest.2011.83 CrossRefPubMed

35.

Grenier G, Leblanc E, Faucheux N et al (2013) BMP-9 expression in human traumatic heterotopic ossification: a case report. Skelet Muscle 3:29. doi:10.1186/2044-5040-3-29 CrossRefPubMedCentralPubMed

36.

Evans KN, Potter BK, Brown TS et al (2013) Osteogenic gene expression correlates with development of heterotopic ossification in war wounds. Clin Orthop Relat Res. doi:10.1007/s11999-013-3325-8

37.

Leblanc E, Trensz F, Haroun S et al (2011) BMP-9-induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment. J Bone Miner Res 26:1166–1177. doi:10.1002/jbmr.311 CrossRefPubMed

38.

Peterson JR, De La Rosa S, Sun H et al (2013) Burn injury enhances bone formation in heterotopic ossification model. Ann Surg. doi:10.1097/SLA.0b013e318291da85

39.

Zhang W, Deng Z-L, Chen L et al (2010) Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One 5:e11917. doi:10.1371/journal.pone.0011917 CrossRefPubMedCentralPubMed

40.

41.

King JB (1998) Post-traumatic ectopic calcification in the muscles of athletes: a review. Br J Sports Med 32:287–290CrossRefPubMedCentralPubMed

42.

Yu PB, Deng DY, Lai CS et al (2008) BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 14:1363–1369. doi:10.1038/nm.1888 CrossRefPubMedCentralPubMed

43.

Olmsted-Davis E, Gannon FH, Ozen M et al (2007) Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 170:620–632. doi:10.2353/ajpath.2007.060692 CrossRefPubMedCentralPubMed

44.

Shimono K, Tung W-E, Macolino C et al (2011) Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists. Nat Med 17:454–460. doi:10.1038/nm.2334 CrossRefPubMedCentralPubMed

45.

Zimmermann SM, Würgler-Hauri CC, Wanner GA et al (2013) Echinomycin in the prevention of heterotopic ossification—an experimental antibiotic agent shows promising results in a murine model. Injury 44:570–575. doi:10.1016/j.injury.2012.12.030 CrossRefPubMed

46.

Salisbury E, Rodenberg E, Sonnet C et al (2011) Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem 112:2748–2758. doi:10.1002/jcb.23225 CrossRefPubMedCentralPubMed

47.

Czura CJ, Tracey KJ (2005) Autonomic neural regulation of immunity. J Intern Med 257:156–166. doi:10.1111/j.1365-2796.2004.01442.x CrossRefPubMed

48.

Hong HS, Lee J, Lee E et al (2009) A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med 15:425–435. doi:10.1038/nm.1909 CrossRefPubMed

49.

Mantyh PW (1991) Substance P and the inflammatory and immune response. Ann NY Acad Sci 632:263–271CrossRefPubMed

50.

Yano H, Wershil BK, Arizono N, Galli SJ (1989) Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest 84:1276–1286. doi:10.1172/JCI114295 CrossRefPubMedCentralPubMed

51.

Dilling CF, Wada AM, Lazard ZW et al (2010) Vessel formation is induced prior to the appearance of cartilage in BMP-2-mediated heterotopic ossification. J Bone Miner Res 25:1147–1156. doi:10.1359/jbmr.091031 PubMedCentralPubMed

52.

Nauth A, Giles E, Potter BK et al (2012) Heterotopic ossification in orthopaedic trauma. J Orthop Trauma 26:684–688. doi:10.1097/BOT.0b013e3182724624 CrossRefPubMedCentralPubMed

53.

Kaplan FS, Glaser DL, Hebela N, Shore EM (2004) Heterotopic ossification. J Am Acad Orthop Surg 12:116–125PubMed

54.

Kaplan FS, Glaser DL, Shore EM et al (2007) Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89:347–357. doi:10.2106/JBJS.F.00472 CrossRefPubMed

55.

Suda RK, Billings PC, Egan KP et al (2009) Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells 27:2209–2219. doi:10.1002/stem.150 CrossRefPubMedCentralPubMed

56.

Barbato M, D’Angelo E, Di Loreto G et al (2012) Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey. J Orthop Traumatol Off J Italian Soc Orthop Traumatol. doi:10.1007/s10195-012-0180-4

57.

Romanò CL, Duci D, Romanò D et al (2004) Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 19:14–18CrossRefPubMed

58.

Brunnekreef JJ, Hoogervorst P, Ploegmakers MJ et al (2013) Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty? Int Orthop 37:583–587. doi:10.1007/s00264-013-1781-0 CrossRefPubMedCentralPubMed

59.

Lavernia CJ, Contreras JS, Villa JM, Rossi MD (2013) Celecoxib and heterotopic bone formation after total hip arthroplasty. J Arthroplasty. doi:10.1016/j.arth.2013.06.039 PubMed

60.

Sheybani A, Tennapel MJ, Lack WD et al (2014) Risk of radiation-induced malignancy with heterotopic ossification prophylaxis: a case-control analysis. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2014.03.008 PubMed

61.

Strauss JB, Chen SS, Shah AP et al (2008) Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty. Int J Radiat Oncol Biol Phys 71:1460–1464. doi:10.1016/j.ijrobp.2007.12.006 CrossRefPubMed

62.

Vavken P, Castellani L, Sculco TP (2009) Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis. Clin Orthop Relat Res 467:3283–3289. doi:10.1007/s11999-009-0924-5 CrossRefPubMedCentralPubMed

63.

Visser Penny S, Krosnick Jon A, Marquette Jesse, Curtin Michael (1996) Mail Surveys for Election Forecasting? An Evaluation of the Colombia Dispatch Poll. Public Opinion Quarterly 60(181):227

64.

Keeter Scott, Kennedy Courtney, Dimock Michael et al (2006) Gauging the impact of growing nonresponse on estimates from a national RDD telephone survey. Public Opinion Quarterly 70:759–779CrossRef

65.

66.

Sheng N, Xie Z, Wang C et al (2010) Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1. Proc Natl Acad Sci USA 107:18886–18891. doi:10.1073/pnas.1009244107 CrossRefPubMedCentralPubMed

67.

Mu X, Usas A, Tang Y et al (2013) RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice. FASEB J 27:3619–3631. doi:10.1096/fj.13-233460 CrossRefPubMedCentralPubMed

68.

Kan L, Lounev VY, Pignolo RJ et al (2011) Substance P signaling mediates BMP-dependent heterotopic ossification. J Cell Biochem 112:2759–2772. doi:10.1002/jcb.23259 CrossRefPubMedCentralPubMed

Titel: Pathogenesis and prevention strategies of heterotopic ossification in total hip arthroplasty: a narrative literature review and results of a survey in Germany
verfasst von: S. Winkler
B. Craiovan
F. Wagner
M. Weber
J. Grifka
T. Renkawitz
Publikationsdatum: 01.04.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Orthopaedic and Trauma Surgery / Ausgabe 4/2015
Print ISSN: 0936-8051
Elektronische ISSN: 1434-3916
DOI: https://doi.org/10.1007/s00402-015-2174-1

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Pathogenesis and prevention strategies of heterotopic ossification in total hip arthroplasty: a narrative literature review and results of a survey in Germany

Abstract

Introduction

Materials and methods

Results

Conclusions

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Update Orthopädie und Unfallchirurgie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction

Materials and methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial

Retrospective lumbar fusion outcomes measured by ODI sub-functions of 100 consecutive procedures

The effect of antegrade femoral nailing on femoral head perfusion: a comparison of piriformis fossa and trochanteric entry points

Electromyographic analysis: shoulder muscle activity revisited

Anatomy and classification of the posterior tibial fragment in ankle fractures

Survey on the management of acute first-time anterior shoulder dislocation amongst Dutch public hospitals

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Update Orthopädie und Unfallchirurgie